← Evidence map

ArticleCell cycle (Georgetown, Tex.)2024

The sorafenib resistance-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma.

Tianxin Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38444181